Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015200
Filing Date
2025-06-02
Accepted
2025-06-02 17:00:14
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 form4-06022025_050604.html 4  
1 form4-06022025_050604.xml 4 4261
  Complete submission text file 0001415889-25-015200.txt   5848
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Issuer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AZIYO BIOLOGICS, INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904
Business Address
Jordan Maybelle (Reporting) CIK: 0001826123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39577 | Film No.: 251015899